Awakn Life Sciences Corp (TSE:AWKN) has released an update.
Awakn Life Sciences Corp., a biotech firm specializing in treatments for addiction, particularly Alcohol Use Disorder, is set to file its annual financial statements by May 30, 2024, after a switch to the Canadian Securities Exchange impacted its filing deadline. The company is currently at risk of a cease-trade order by the Ontario Securities Commission for late submission but is seeking a management cease trade order to allow trading by non-insiders. Regular updates will be provided until the financial documents are filed and the company emphasizes no other undisclosed material information exists.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.
